Charachterization and functional analysis of scFv-based CARs to redirect T cells to IL13Rα2-positive glioma

Documenti analoghi

• IM-02 A scFv-BASED CAR TO REDIRECT T CELLS TO IL13Rα2-POSITIVE PEDIATRIC GLIOMA
  di: Krenciute, Giedre, et al.
  Pubblicazione: (2015)
• Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma
  di: Krenciute, Giedre, et al.
  Pubblicazione: (2016)
• Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
  di: Kang, Chung Hyo, et al.
  Pubblicazione: (2020)
• IMMU-17. TRANSGENIC EXPRESSION OF IL15 IMPROVES ANTIGLIOMA ACTIVITY OF IL13RΑ2-CAR T CELLS
  di: Steffin, David, et al.
  Pubblicazione: (2017)
• EXTH-32. TRANSGENIC EXPRESSION OF IL15 IMPROVES THE EFFICACY OF CAR T CELLS IN AN IMMUNE COMPETENT GLIOBLASTOMA MODEL
  di: Pituch, Katarzyna, et al.
  Pubblicazione: (2018)